tiprankstipranks
Trending News
More News >
Abbott Laboratories (CH:ABT)
:ABT
Switzerland Market

Abbott Laboratories (ABT) Ratios

Compare
1 Followers

Abbott Laboratories Ratios

CH:ABT's free cash flow for Q1 2025 was $0.57. For the 2025 fiscal year, CH:ABT's free cash flow was decreased by $ and operating cash flow was $0.18. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.78 1.64 1.63 1.85 1.72
Quick Ratio
1.27 1.16 1.23 1.46 1.30
Cash Ratio
0.50 0.50 0.64 0.75 0.57
Solvency Ratio
0.51 0.26 0.27 0.27 0.20
Operating Cash Flow Ratio
0.69 0.52 0.62 0.80 0.66
Short-Term Operating Cash Flow Coverage
17.69 6.72 4.26 13.97 35.91
Net Current Asset Value
$ -9.23B$ -11.72B$ -12.31B$ -14.93B$ -19.10B
Leverage Ratios
Debt-to-Assets Ratio
0.16 0.22 0.24 0.25 0.27
Debt-to-Equity Ratio
0.27 0.41 0.48 0.53 0.60
Debt-to-Capital Ratio
0.21 0.29 0.33 0.35 0.37
Long-Term Debt-to-Capital Ratio
0.21 0.26 0.28 0.33 0.36
Financial Leverage Ratio
1.67 1.90 2.03 2.10 2.21
Debt Service Coverage Ratio
17.83 5.63 4.19 9.33 11.52
Interest Coverage Ratio
15.39 10.17 22.30 17.19 10.71
Debt to Market Cap
0.06 0.08 0.09 0.07 0.10
Interest Debt Per Share
7.85 9.52 10.32 10.98 11.36
Net Debt to EBITDA
0.60 0.85 0.63 0.72 1.46
Profitability Margins
Gross Profit Margin
55.89%55.18%56.15%56.97%56.65%
EBIT Margin
18.70%18.20%20.31%20.30%15.93%
EBITDA Margin
26.45%26.44%28.36%29.58%25.40%
Operating Profit Margin
16.97%16.15%19.16%19.56%15.48%
Pretax Profit Margin
17.37%16.61%19.03%19.06%14.36%
Net Profit Margin
31.89%14.27%15.88%16.42%12.99%
Continuous Operations Profit Margin
31.89%14.27%15.88%16.42%12.92%
Net Income Per EBT
183.58%85.88%83.47%86.12%90.48%
EBT Per EBIT
102.35%102.87%99.33%97.46%92.74%
Return on Assets (ROA)
16.58%7.82%9.31%9.40%6.20%
Return on Equity (ROE)
30.76%14.83%18.90%19.75%13.71%
Return on Capital Employed (ROCE)
10.50%10.91%14.19%13.57%8.83%
Return on Invested Capital (ROIC)
19.13%9.17%11.36%11.50%7.89%
Return on Tangible Assets
26.05%14.05%16.83%18.03%13.21%
Earnings Yield
5.81%3.00%3.60%2.83%2.32%
Efficiency Ratios
Receivables Turnover
4.38 6.11 7.02 6.64 5.40
Payables Turnover
4.43 4.19 4.15 4.21 3.80
Inventory Turnover
2.81 2.74 3.10 3.59 2.99
Fixed Asset Turnover
3.87 3.56 4.76 4.81 3.83
Asset Turnover
0.52 0.55 0.59 0.57 0.48
Working Capital Turnover Ratio
4.31 4.32 4.18 4.38 5.19
Cash Conversion Cycle
130.74 105.94 81.85 69.72 93.58
Days of Sales Outstanding
83.35 59.74 51.99 54.97 67.65
Days of Inventory Outstanding
129.74 133.41 117.71 101.54 121.93
Days of Payables Outstanding
82.35 87.21 87.85 86.80 96.00
Operating Cycle
213.09 193.15 169.70 156.51 189.58
Cash Flow Ratios
Operating Cash Flow Per Share
5.12 4.19 5.47 5.93 4.46
Free Cash Flow Per Share
3.81 2.92 4.45 4.87 3.23
CapEx Per Share
1.04 1.27 1.01 1.06 1.23
Free Cash Flow to Operating Cash Flow
0.74 0.70 0.81 0.82 0.72
Dividend Paid and CapEx Coverage Ratio
1.57 1.26 1.88 2.07 1.67
Capital Expenditure Coverage Ratio
4.95 3.30 5.39 5.59 3.63
Operating Cash Flow Coverage Ratio
0.68 0.46 0.54 0.55 0.40
Operating Cash Flow to Sales Ratio
0.21 0.18 0.22 0.24 0.23
Free Cash Flow Yield
2.88%2.65%4.05%3.46%2.95%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
17.21 33.35 27.76 35.33 43.19
Price-to-Sales (P/S) Ratio
5.46 4.76 4.41 5.80 5.61
Price-to-Book (P/B) Ratio
4.76 4.94 5.25 6.98 5.92
Price-to-Free Cash Flow (P/FCF) Ratio
34.76 37.73 24.66 28.89 33.91
Price-to-Operating Cash Flow Ratio
25.96 26.29 20.09 23.72 24.57
Price-to-Earnings Growth (PEG) Ratio
26.64 -2.05 -36.74 0.61 1.99
Price-to-Fair Value
4.76 4.94 5.25 6.98 5.92
Enterprise Value Multiple
21.26 18.84 16.18 20.33 23.54
Enterprise Value
238.09B 199.85B 200.30B 259.02B 206.94B
EV to EBITDA
21.26 18.84 16.18 20.33 23.54
EV to Sales
5.62 4.98 4.59 6.01 5.98
EV to Free Cash Flow
35.77 39.50 25.67 29.95 36.15
EV to Operating Cash Flow
26.60 27.52 20.91 24.59 26.19
Tangible Book Value Per Share
11.13 3.65 2.08 0.03 -3.12
Shareholders’ Equity Per Share
27.94 22.26 20.93 20.17 18.49
Tax and Other Ratios
Effective Tax Rate
-0.84 0.14 0.17 0.14 0.10
Revenue Per Share
24.24 23.13 24.90 24.27 19.52
Net Income Per Share
7.73 3.30 3.95 3.98 2.54
Tax Burden
1.84 0.86 0.83 0.86 0.90
Interest Burden
0.93 0.91 0.94 0.94 0.90
Research & Development to Revenue
0.07 0.07 0.07 0.06 0.07
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.02 0.02 0.02 0.01 0.02
Income Quality
0.67 1.27 1.38 1.49 1.76
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis